Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar
NCT06218277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2024-09-19
Summary
The investigators want to investigate the clinical impact of early antimicrobial susceptibility results for gram negative bacilli isolated from blood cultures on antimicrobial choices and early switches of antimicrobial therapy.
Conditions
- Bacteremia
Interventions
- DIAGNOSTIC_TEST
-
ASTAR
Rapid AST with ASTAR
Sponsors & Collaborators
-
University Hospital, Ghent
lead OTHER
Principal Investigators
-
Jerina Boelens · University Hospital, Ghent
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-10
- Primary Completion
- 2024-08-31
- Completion
- 2024-08-31
Countries
- Belgium
Study Locations
More Related Trials
-
Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.
NCT03007290 ·Status: COMPLETED ·Phase: NA
-
Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia
NCT03218397 ·Status: COMPLETED ·Phase: NA
-
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia
NCT05613322 ·Status: TERMINATED
-
Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis
NCT05002413 ·Status: COMPLETED
-
Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases
NCT03611257 ·Status: COMPLETED ·Phase: NA
-
Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections
NCT02060513 ·Status: COMPLETED
-
Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients
NCT01114165 ·Status: COMPLETED ·Phase: PHASE4
-
Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii
NCT03622918 ·Status: COMPLETED ·Phase: NA
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
Early Oral Switch for Uncomplicated Gram-negative Bacteraemia
NCT05199324 ·Status: RECRUITING ·Phase: PHASE4
-
Detection of Colistin-resistant Isolates From Patients of Intensive Care Units and Oncohaematology Wards.
NCT03971877 ·Status: COMPLETED
-
DetectAB - Detecting Antibiotics
NCT03678142 ·Status: COMPLETED
-
Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients with Enterobacterales Bacteremia
NCT06425367 ·Status: RECRUITING ·Phase: NA
-
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961 ·Status: COMPLETED
-
Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin
NCT01845246 ·Status: COMPLETED ·Phase: NA
-
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
NCT00235690 ·Status: COMPLETED ·Phase: NA
-
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
NCT01792804 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiotic Wave I Updates
NCT04295915 ·Status: COMPLETED
-
Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study
NCT03000049 ·Status: UNKNOWN
-
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
NCT01191840 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
NCT06069206 ·Status: COMPLETED ·Phase: NA
-
Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients
NCT03557840 ·Status: UNKNOWN ·Phase: NA
-
Negative Predictive Value and NIC of Beta-Lactam Antibiotics.
NCT04126096 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections
NCT05942157 ·Status: RECRUITING ·Phase: NA
-
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
NCT05210387 ·Status: TERMINATED ·Phase: NA